Chuo Gyorui Co., Ltd. (8030.T)
JPY 3710.0
(-2.24%)
JPY 3710.0
(-2.24%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.59 Billion | 3.34 Billion | -814 Million | 5.42 Billion | 5.79 Billion |
| Net Income | 2.84 Billion | 2.3 Billion | 2.48 Billion | 1.89 Billion | 683 Million |
| Depreciation & Amortization | 2.27 Billion | 2.24 Billion | 2.18 Billion | 2.22 Billion | 2.3 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -780 Million | -270 Million | -4.3 Billion | 1.27 Billion | 2.64 Billion |
| Other non-cash items | 287 Million | 53 Million | -550 Million | 576 Million | 2.5 Billion |
| Investing Cash Flow | -637 Million | -666 Million | -795 Million | -1.83 Billion | -3.38 Billion |
| Investments in PPE | -1.4 Billion | -985 Million | -1.86 Billion | -1.43 Billion | -3.52 Billion |
| Acquisitions | 20 Million | 355 Million | 115 Million | 622 Million | 105 Million |
| Investment purchases | -13 Million | -122 Million | -5 Million | -7 Million | -2 Million |
| Sales/Maturities of investments | 712 Million | 38 Million | 133 Million | 306 Million | 16 Million |
| Other Investing Activities | 82 Million | 122 Million | 210 Million | 204 Million | 29 Million |
| Financing Cash Flow | -4.2 Billion | -1.85 Billion | -453 Million | -1.65 Billion | -2.24 Billion |
| Debt repayment | -3.57 Billion | -3.29 Billion | -124 Million | -1.07 Billion | -1.91 Billion |
| Dividends payments | -279 Million | -279 Million | -237 Million | -239 Million | -239 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -71 Million | -4.58 Billion | -1 Million | -2 Million | -87 Million |
| Accounts receivables | -1.91 Billion | -743 Million | -1.19 Billion | 326 Million | 3.04 Billion |
| Accounts payables | 2.26 Billion | 693 Million | 590 Million | 694 Million | -2.33 Billion |
| Inventory | -1.1 Billion | -641 Million | -2.8 Billion | 144 Million | 1.56 Billion |
| Other working capital | 319 Million | 487 Million | -1.07 Billion | 510 Million | 382 Million |
| Cash at beginning of period | 8.35 Billion | 7.53 Billion | 9.57 Billion | 7.64 Billion | 7.48 Billion |
| Cash at end of period | 7.09 Billion | 8.35 Billion | 7.53 Billion | 9.57 Billion | 7.64 Billion |
| Capital Expenditure | -1.4 Billion | -985 Million | -1.86 Billion | -1.43 Billion | -3.52 Billion |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -1.25 Billion | 818 Million | -2.04 Billion | 1.93 Billion | 164 Million |
| Free Cash Flow | 2.18 Billion | 2.35 Billion | -2.67 Billion | 3.98 Billion | 2.26 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 791 Million | 2.84 Billion | 376 Million | 597 Million | 690 Million | 471 Million |
| Depreciation & Amortization | - | 2.27 Billion | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -780 Million | - | - | - | - |
| Other non-cash items | -791 Million | 287 Million | -376 Million | -597 Million | -690 Million | -471 Million |
| Investing Cash Flow | - | -637 Million | - | - | - | - |
| Investments in PPE | - | -1.4 Billion | - | - | - | - |
| Acquisitions | - | 20 Million | - | - | - | - |
| Investment purchases | - | -13 Million | - | - | - | - |
| Sales/Maturities of investments | - | 712 Million | - | - | - | - |
| Other Investing Activities | - | 82 Million | - | - | - | - |
| Financing Cash Flow | - | -4.2 Billion | - | - | - | - |
| Debt repayment | - | -3.57 Billion | - | - | - | - |
| Dividends payments | - | -279 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -71 Million | - | - | - | - |
| Accounts receivables | - | -1.91 Billion | - | - | - | - |
| Accounts payables | - | 2.26 Billion | - | - | - | - |
| Inventory | - | -1.1 Billion | - | - | - | - |
| Other working capital | - | 319 Million | - | - | - | - |
| Cash at beginning of period | - | 8.35 Billion | - | - | - | - |
| Cash at end of period | - | 7.09 Billion | - | - | - | - |
| Capital Expenditure | - | -1.4 Billion | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -1.25 Billion | - | - | - | - |
| Free Cash Flow | - | 2.18 Billion | - | - | - | - |
8060
1468
NFC
AUROPHARMA
3075
9385